Holmes GP, Chapman LE, Stewart JA, Straus SE, Hilliard JK, Davenport DS. The B virus Working Group. Guidelines for the prevention and treatment of B-virus infections in exposed persons. Clin Infect Dis 1995;20:421-39.
Focher F, Lossani A, Verri A, Spadari S, Maioli A, Gambino JJ, et al. Sensitivity of monkey B virus (Cercopithecine herpesvirus 1) to antiviral drugs: role of thymidine kinase in antiviral activities of substrate analogs and acyclonucleosides. Antimicrob Agents Chemother 2007;51:2028-34.
Perelygina L, Patrusheva I, Manes N, Wildes MJ, Krug P, Hilliard JK. Quantitative real-time PCR for detection of monkey B virus (Cercopithecine herpesvirus 1) in clinical samples. J Virol Methods 2003;109:245-51.
National Research Council. Occupational health and safety in the care and use of nonhuman primates. Washington, DC: National Academy Press, 2003.
Black DH, Saliki JT, Eberle R. Development of a green fluorescent protein reporter cell line to reduce biohazards associated with detection of infectious Cercopithecine herpesvirus 1 (monkey B virus) in clinical specimens. Comp Med 2002;52:534-42.
National Institute for Occupational Safety and Health. Cercopithecine herpesvirus 1 (B virus) infection resulting from ocular exposure. Appl Occup Environ Hyg 2001;16:32-4.
Weigler BJ, Scinicariello F, Hilliard JK. Risk of venereal B virus (Cercopithecine herpesvirus 1) transmission in rhesus monkeys using molecular epidemiology. J Infect Dis 1995;171:1139-43.
Weigler BJ, Hird DW, Hilliard JK, Lerche NW, Roberts JA, Scott LM. Epidemiology of Cercopithecine herpesvirus 1 (B virus) infection and shedding in a large breeding cohort of rhesus macaques. J Infect Dis 1993;167:257-63.